Timothy E Morris's Net Worth
$6.28 Million
Who is Timothy E Morris?
Timothy E Morris has an estimated net worth of $6.28 Million. This is based on reported shares across multiple companies, which include IOVANCE BIOTHERAPEUTICS, INC., DBV Technologies S.A., HUMANIGEN, INC, ACELRX PHARMACEUTICALS INC, Aquestive Therapeutics, Inc., QUESTCOR PHARMACEUTICALS INC, and VIVUS INC.
SEC CIK
Timothy E Morris's CIK is 0001191286
Past Insider Trading and Trends
2012 was Timothy E Morris's most active year for acquiring shares with 13 total transactions. Timothy E Morris's most active month to acquire stocks was the month of December. 2012 was Timothy E Morris's most active year for disposing of shares, totalling 22 transactions. Timothy E Morris's most active month to dispose stocks was the month of January. 2012 saw Timothy E Morris paying a total of $1,788,585.70 for 444,358 shares, this is the most they've acquired in one year. In 2012 Timothy E Morris cashed out on 708,716 shares for a total of $7,761,417.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Snapshot price: $8.17
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DBV Technologies S.A. (DBVT) Snapshot price: $0.908
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12K |
$1.52 | $18,240.00 | 12K |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HUMANIGEN, INC (HGEN) Snapshot price: $0.0002
COO and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELRX PHARMACEUTICALS INC (ACRX) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
| No matching records found | |||||||||